Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
Swiss Cancer Institute
Swiss Cancer Institute
Weill Medical College of Cornell University
Emory University
Merck Sharp & Dohme LLC
Duke University
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)